Čájehuvvojit 1 - 7 oktiibuot 7 bohtosis ohcui "pharmacovigilance"', ohcanáigi: 0,01s Aiddostahte ozu
  1. 1
    Table 2_A pharmacovigilance study of Bruton’s tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase.xlsx

    Table 2_A pharmacovigilance study of Bruton’s tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase.xlsx Dahkki Han Qu (4391905)

    Almmustuhtton 2025
    Fáttát:
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Table 1_A pharmacovigilance study of Bruton’s tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase.docx

    Table 1_A pharmacovigilance study of Bruton’s tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase.docx Dahkki Han Qu (4391905)

    Almmustuhtton 2025
    Fáttát:
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Table 1_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx

    Table 1_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx Dahkki Satoko Watanabe (59124)

    Almmustuhtton 2025
    Fáttát:
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Table 3_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx

    Table 3_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx Dahkki Satoko Watanabe (59124)

    Almmustuhtton 2025
    Fáttát:
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Table 4_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx

    Table 4_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx Dahkki Satoko Watanabe (59124)

    Almmustuhtton 2025
    Fáttát:
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Data Sheet 1_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.pdf

    Data Sheet 1_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.pdf Dahkki Satoko Watanabe (59124)

    Almmustuhtton 2025
    Fáttát:
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Table 2_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx

    Table 2_Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases.xlsx Dahkki Satoko Watanabe (59124)

    Almmustuhtton 2025
    Fáttát:
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: